Lin Chen
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Circular RNAs in diseases 33
- RNA modifications and cancer 12
- Glycosylation and Glycoproteins Research 10
-
- MicroRNA in disease regulation 45
- Cancer-related molecular mechanisms research 25
- Co-authors
- Shanliang Zhong (9 shared papers)Jianhua Zhao (8 shared papers)Jinhai Tang (8 shared papers)Diane Mathis (1 shared paper)Steven F. Ziegler (1 shared paper)Vigo Heissmeyer (1 shared paper)Liang Guo (1 shared paper)Anjana Rao (1 shared paper)
- Journals
- PLoS ONE (9 papers)Oncotarget (5 papers)Cellular Physiology and Biochemistry (5 papers)Head & Neck (4 papers)Medicine (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lin Chen
215 papers receiving 7.1k citations
Lin Chen's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 2.3k
- Immunology 1.3k
- Molecular Biology 3.7k
- Oncology 1.3k
- Cell Biology 355
Countries citing papers authored by Lin Chen
This map shows the geographic impact of Lin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Chen more than expected).
Fields of papers citing papers by Lin Chen
This network shows the impact of papers produced by Lin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Chen. The network helps show where Lin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT Hit paper breakdown → | 2006 | 967 |
| 2 | 2014 | 372 | |
| 3 | 1998 | 285 | |
| 4 | 2009 | 211 | |
| 5 | 2010 | 210 | |
| 6 | 2010 | 181 | |
| 7 | 2011 | 166 | |
| 8 | 2015 | 161 | |
| 9 | 2014 | 131 | |
| 10 | 1999 | 131 | |
| 11 | 2019 | 130 | |
| 12 | 2007 | 111 | |
| 13 | 2016 | 109 | |
| 14 | 2014 | 104 | |
| 15 | 2004 | 87 | |
| 16 | 1998 | 87 | |
| 17 | 2012 | 86 | |
| 18 | 2013 | 85 | |
| 19 | 2021 | 84 | |
| 20 | 2017 | 76 |
About Lin Chen
Lin Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 229 papers that have together received 7.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (45 papers), Circular RNAs in diseases (33 papers), Cancer-related molecular mechanisms research (25 papers), Cancer Cells and Metastasis (13 papers), RNA modifications and cancer (12 papers), Glycosylation and Glycoproteins Research (10 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (2.3k citations), Immunology (1.3k citations), Molecular Biology (3.7k citations), Oncology (1.3k citations) and Cell Biology (355 citations). Lin Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shanliang Zhong, Jianhua Zhao, Jinhai Tang, Diane Mathis, Steven F. Ziegler, Vigo Heissmeyer, Liang Guo, Anjana Rao, James C. Stroud and Ariya D. Lapan. Their work appears in journals such as PLoS ONE, Oncotarget, Cellular Physiology and Biochemistry, Head & Neck and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.